<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-04-01" modified="2020-08-12" version="217">
<accession>P29965</accession>
<name>CD40L_HUMAN</name>
<protein>
<recommendedName>
<fullName>CD40 ligand</fullName>
<shortName>CD40-L</shortName>
</recommendedName>
<alternativeName>
<fullName>T-cell antigen Gp39</fullName>
</alternativeName>
<alternativeName>
<fullName>TNF-related activation protein</fullName>
<shortName>TRAP</shortName>
</alternativeName>
<alternativeName>
<fullName>Tumor necrosis factor ligand superfamily member 5</fullName>
</alternativeName>
<cdAntigenName>CD154</cdAntigenName>
<component>
<recommendedName>
<fullName>CD40 ligand, membrane form</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName evidence="26">CD40 ligand, soluble form</fullName>
<shortName evidence="25">sCD40L</shortName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">CD40LG</name>
<name type="synonym">CD40L</name>
<name type="synonym">TNFSF5</name>
<name type="synonym">TRAP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Eur. J. Immunol." volume="22" first="3191" last="3194">
<title>Cloning of TRAP, a ligand for CD40 on human T cells.</title>
<authorList>
<person name="Graf D."/>
<person name="Korthaeuer U."/>
<person name="Mages H.W."/>
<person name="Senger G."/>
<person name="Kroczek R.A."/>
</authorList>
<dbReference type="PubMed" id="1280226"/>
<dbReference type="DOI" id="10.1002/eji.1830221226"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="EMBO J." volume="11" first="4313" last="4321">
<title>The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.</title>
<authorList>
<person name="Hollenbaugh D."/>
<person name="Grosmaire L.S."/>
<person name="Kullas C.D."/>
<person name="Chalupny J.N."/>
<person name="Braesch-Andersen S."/>
<person name="Noelle R.J."/>
<person name="Stamenkovic I."/>
<person name="Ledbetter J.A."/>
<person name="Aruffo A."/>
</authorList>
<dbReference type="PubMed" id="1385114"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1992.tb05530.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1993" name="Cell" volume="72" first="291" last="300">
<title>The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.</title>
<authorList>
<person name="Aruffo A."/>
<person name="Farrington M."/>
<person name="Hollenbaugh D."/>
<person name="Li X."/>
<person name="Milatovich A."/>
<person name="Nonoyama S."/>
<person name="Bajorath J."/>
<person name="Grosmaire L.S."/>
<person name="Stenkamp R."/>
<person name="Neubauer M."/>
<person name="Roberts R.L."/>
<person name="Noelle R.J."/>
<person name="Ledbetter J.A."/>
<person name="Francke U."/>
<person name="Ochs H.D."/>
</authorList>
<dbReference type="PubMed" id="7678782"/>
<dbReference type="DOI" id="10.1016/0092-8674(93)90668-g"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS HIGM1 128-ARG-GLY-129 AND PRO-235</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1992" name="J. Exp. Med." volume="176" first="1543" last="1550">
<title>Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.</title>
<authorList>
<person name="Spriggs M.K."/>
<person name="Armitage R.J."/>
<person name="Strockbine L."/>
<person name="Clifford K.N."/>
<person name="Macduff B.M."/>
<person name="Sato T.A."/>
<person name="Maliszewski C.R."/>
<person name="Fanslow W.C."/>
</authorList>
<dbReference type="PubMed" id="1281209"/>
<dbReference type="DOI" id="10.1084/jem.176.6.1543"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1993" name="FEBS Lett." volume="315" first="259" last="266">
<title>Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production.</title>
<authorList>
<person name="Gauchat J.-F."/>
<person name="Aubry J.-P."/>
<person name="Mazzei G.J."/>
<person name="Life P."/>
<person name="Jomotte T."/>
<person name="Elson G."/>
<person name="Bonnefoy J.-Y."/>
</authorList>
<dbReference type="PubMed" id="7678552"/>
<dbReference type="DOI" id="10.1016/0014-5793(93)81175-y"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1995" name="Biochim. Biophys. Acta" volume="1260" first="67" last="72">
<title>Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome.</title>
<authorList>
<person name="Shimadzu M."/>
<person name="Nunoi H."/>
<person name="Terasaki H."/>
<person name="Ninomiya R."/>
<person name="Iwata M."/>
<person name="Kanegasaka S."/>
<person name="Matsuda I."/>
</authorList>
<dbReference type="PubMed" id="7999797"/>
<dbReference type="DOI" id="10.1016/0167-4781(94)00179-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="5965" last="5967">
<title>Human native soluble CD40L is a biologically active trimer, processed inside microsomes.</title>
<authorList>
<person name="Pietravalle F."/>
<person name="Lecoanet-Henchoz S."/>
<person name="Blasey H."/>
<person name="Aubry J.-P."/>
<person name="Elson G."/>
<person name="Edgerton M.D."/>
<person name="Bonnefoy J.-Y."/>
<person name="Gauchat J.-F."/>
</authorList>
<dbReference type="PubMed" id="8626375"/>
<dbReference type="DOI" id="10.1074/jbc.271.11.5965"/>
</citation>
<scope>PROTEIN SEQUENCE OF 113-117</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="J. Immunol." volume="156" first="3133" last="3140">
<title>Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis.</title>
<authorList>
<person name="Blotta M.H."/>
<person name="Marshall J.D."/>
<person name="DeKruyff R.H."/>
<person name="Umetsu D.T."/>
</authorList>
<dbReference type="PubMed" id="8617933"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Protein Expr. Purif." volume="23" first="301" last="310">
<title>Determination of carbohydrate structures N-linked to soluble CD154 and characterization of the interactions of CD40 with CD154 expressed in Pichia pastoris and Chinese hamster ovary cells.</title>
<authorList>
<person name="Khandekar S.S."/>
<person name="Silverman C."/>
<person name="Wells-Marani J."/>
<person name="Bacon A.M."/>
<person name="Birrell H."/>
<person name="Brigham-Burke M."/>
<person name="DeMarini D.J."/>
<person name="Jonak Z.L."/>
<person name="Camilleri P."/>
<person name="Fishman-Lobell J."/>
</authorList>
<dbReference type="PubMed" id="11676606"/>
<dbReference type="DOI" id="10.1006/prep.2001.1501"/>
</citation>
<scope>GLYCOSYLATION AT ASN-240</scope>
<scope>STRUCTURE OF CARBOHYDRATE ON ASN-240</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="J. Am. Coll. Cardiol." volume="43" first="2319" last="2325">
<title>Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.</title>
<authorList>
<person name="Furman M.I."/>
<person name="Krueger L.A."/>
<person name="Linden M.D."/>
<person name="Barnard M.R."/>
<person name="Frelinger A.L. III"/>
<person name="Michelson A.D."/>
</authorList>
<dbReference type="PubMed" id="15193700"/>
<dbReference type="DOI" id="10.1016/j.jacc.2003.12.055"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="J. Exp. Med." volume="199" first="1025" last="1031">
<title>The modulation of CD40 ligand signaling by transmembrane CD28 splice variant in human T cells.</title>
<authorList>
<person name="Mikolajczak S.A."/>
<person name="Ma B.Y."/>
<person name="Yoshida T."/>
<person name="Yoshida R."/>
<person name="Kelvin D.J."/>
<person name="Ochi A."/>
</authorList>
<dbReference type="PubMed" id="15067037"/>
<dbReference type="DOI" id="10.1084/jem.20031705"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2019" name="J. Immunol." volume="203" first="1383" last="1391">
<title>Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling.</title>
<authorList>
<person name="Takada Y.K."/>
<person name="Yu J."/>
<person name="Shimoda M."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="31331973"/>
<dbReference type="DOI" id="10.4049/jimmunol.1801630"/>
</citation>
<scope>FUNCTION AS CD40 AND INTEGRIN LIGAND</scope>
<scope>CHARACTERIZATION OF VARIANTS HIGM1 CYS-170; ARG-174; ILE-176; ASP-208; TYR-224; ALA-226; VAL-227 AND SER-258</scope>
<scope>MUTAGENESIS OF TYR-170; HIS-224; GLY-226 AND GLY-252</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1995" name="Structure" volume="3" first="1031" last="1039">
<title>2-A crystal structure of an extracellular fragment of human CD40 ligand.</title>
<authorList>
<person name="Karpsusas M."/>
<person name="Hsu Y.-M."/>
<person name="Wang J.-H."/>
<person name="Thompson J."/>
<person name="Lederman S."/>
<person name="Chess L."/>
<person name="Thomas D."/>
</authorList>
<dbReference type="PubMed" id="8589998"/>
<dbReference type="DOI" id="10.1016/s0969-2126(01)00239-8"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 116-261</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1998" name="Protein Sci." volume="7" first="1124" last="1135">
<title>The role of polar interactions in the molecular recognition of CD40L with its receptor CD40.</title>
<authorList>
<person name="Singh J."/>
<person name="Garber E."/>
<person name="van Vlijmen H."/>
<person name="Karpsusas M."/>
<person name="Hsu Y.-M."/>
<person name="Zheng Z."/>
<person name="Naismith J.H."/>
<person name="Thomas D."/>
</authorList>
<dbReference type="PubMed" id="9605317"/>
<dbReference type="DOI" id="10.1002/pro.5560070506"/>
</citation>
<scope>3D-STRUCTURE MODELING OF COMPLEX WITH CD40</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1993" name="Nature" volume="361" first="539" last="541">
<title>Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.</title>
<authorList>
<person name="Korthaeuer U."/>
<person name="Graf D."/>
<person name="Mages H.W."/>
<person name="Briere F."/>
<person name="Padayachee M."/>
<person name="Malcolm S."/>
<person name="Ugazio A.G."/>
<person name="Notarangelo L.D."/>
<person name="Levinsky R.J."/>
<person name="Kroczek R.A."/>
</authorList>
<dbReference type="PubMed" id="7679206"/>
<dbReference type="DOI" id="10.1038/361539a0"/>
</citation>
<scope>VARIANTS HIGM1 ARG-36 AND GLY-140</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1993" name="Nature" volume="361" first="541" last="543">
<title>CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM.</title>
<authorList>
<person name="Disanto J.P."/>
<person name="Bonnefoy J.-Y."/>
<person name="Gauchat J.-F."/>
<person name="Fischer A."/>
<person name="de Saint Basile G."/>
</authorList>
<dbReference type="PubMed" id="8094231"/>
<dbReference type="DOI" id="10.1038/361541a0"/>
</citation>
<scope>VARIANT HIGM1 GLU-123</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1993" name="Science" volume="259" first="990" last="993">
<title>CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.</title>
<authorList>
<person name="Allen R.C."/>
<person name="Armitage R.J."/>
<person name="Conley M.E."/>
<person name="Rosenblatt H."/>
<person name="Jenkins N.A."/>
<person name="Copeland N.G."/>
<person name="Bedell M.A."/>
<person name="Edelhoff S."/>
<person name="Disteche C.M."/>
<person name="Simoneaux D.K."/>
<person name="Fanslow W.C."/>
<person name="Belmont J.W."/>
<person name="Spriggs M.K."/>
</authorList>
<dbReference type="PubMed" id="7679801"/>
<dbReference type="DOI" id="10.1126/science.7679801"/>
</citation>
<scope>VARIANTS HIGM1 PRO-155; ASN-211 AND VAL-227</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1995" name="Am. J. Hum. Genet." volume="56" first="898" last="906">
<title>Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry.</title>
<authorList>
<person name="Macchi P."/>
<person name="Villa A."/>
<person name="Strina D."/>
<person name="Sacco M.G."/>
<person name="Morali F."/>
<person name="Brugnoni D."/>
<person name="Giliani S."/>
<person name="Mantuano E."/>
<person name="Fasth A."/>
<person name="Andersson B."/>
<person name="Zegers B.J.M."/>
<person name="Cavagni G."/>
<person name="Reznick I."/>
<person name="Levy J."/>
<person name="Zan-Bar I."/>
<person name="Porat Y."/>
<person name="Airo P."/>
<person name="Plebani A."/>
<person name="Vezzoni P."/>
<person name="Notarangelo L.D."/>
</authorList>
<dbReference type="PubMed" id="7717401"/>
</citation>
<scope>VARIANTS HIGM1 ALA-126; ARG-140 AND GLU-144</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1995" name="J. Clin. Invest." volume="95" first="510" last="514">
<title>Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.</title>
<authorList>
<person name="Saiki O."/>
<person name="Tanaka T."/>
<person name="Wada Y."/>
<person name="Uda H."/>
<person name="Inoue A."/>
<person name="Katada Y."/>
<person name="Izeki M."/>
<person name="Iwata M."/>
<person name="Nunoi H."/>
<person name="Matsuda I."/>
</authorList>
<dbReference type="PubMed" id="7532185"/>
<dbReference type="DOI" id="10.1172/jci117692"/>
</citation>
<scope>VARIANT HIGM1 GLU-237</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="223" last="228">
<title>Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome.</title>
<authorList>
<person name="Katz F."/>
<person name="Hinshelwood S."/>
<person name="Rutland P."/>
<person name="Jones A."/>
<person name="Kinnon C."/>
<person name="Morgan G."/>
</authorList>
<dbReference type="PubMed" id="8889581"/>
<dbReference type="DOI" id="10.1002/(sici)1098-1004(1996)8:3&lt;223::aid-humu5>3.0.co;2-a"/>
</citation>
<scope>VARIANTS HIGM1 ARG-38; ARG-125; ARG-174 AND SER-257</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1996" name="J. Clin. Invest." volume="97" first="196" last="201">
<title>A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome.</title>
<authorList>
<person name="Lin Q."/>
<person name="Rohrer J."/>
<person name="Allen R.C."/>
<person name="Larche M."/>
<person name="Greene J.M."/>
<person name="Shigeoka A.O."/>
<person name="Gatti R.A."/>
<person name="Derauf D.C."/>
<person name="Belmont J.W."/>
<person name="Conley M.E."/>
</authorList>
<dbReference type="PubMed" id="8550833"/>
<dbReference type="DOI" id="10.1172/jci118389"/>
</citation>
<scope>VARIANTS HIGM1 PRO-155 AND VAL-227</scope>
<scope>VARIANT ARG-219</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1997" name="Hum. Genet." volume="99" first="624" last="627">
<title>Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome.</title>
<authorList>
<person name="Nonoyama S."/>
<person name="Shimadzu M."/>
<person name="Toru H."/>
<person name="Seyama K."/>
<person name="Nunoi H."/>
<person name="Neubauer M."/>
<person name="Yata J."/>
<person name="Och H.D."/>
</authorList>
<dbReference type="PubMed" id="9150729"/>
<dbReference type="DOI" id="10.1007/s004390050417"/>
</citation>
<scope>VARIANTS HIGM1 ARG-36; CYS-140; GLY-227 DEL; SER-231 AND MET-254</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1998" name="Blood" volume="92" first="2421" last="2434">
<title>Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.</title>
<authorList>
<person name="Seyama K."/>
<person name="Nonoyama S."/>
<person name="Gangsaas I."/>
<person name="Hollenbaugh D."/>
<person name="Pabst H.F."/>
<person name="Aruffo A."/>
<person name="Ochs H.D."/>
</authorList>
<dbReference type="PubMed" id="9746782"/>
</citation>
<scope>VARIANTS HIGM1 SER-116; ASN-147; CYS-170; VAL-227; SER-231; PRO-235; MET-254 AND SER-258</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2016" name="Immunogenetics" volume="68" first="19" last="28">
<title>Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.</title>
<authorList>
<person name="Ouadani H."/>
<person name="Ben-Mustapha I."/>
<person name="Ben-ali M."/>
<person name="Ben-khemis L."/>
<person name="Largueche B."/>
<person name="Boussoffara R."/>
<person name="Maalej S."/>
<person name="Fetni I."/>
<person name="Hassayoun S."/>
<person name="Mahfoudh A."/>
<person name="Mellouli F."/>
<person name="Yalaoui S."/>
<person name="Masmoudi H."/>
<person name="Bejaoui M."/>
<person name="Barbouche M.R."/>
</authorList>
<dbReference type="PubMed" id="26545377"/>
<dbReference type="DOI" id="10.1007/s00251-015-0878-6"/>
</citation>
<scope>VARIANT HIGM1 SER-116</scope>
</reference>
<comment type="function">
<text evidence="3 6 7 10 20">Cytokine that acts as a ligand to CD40/TNFRSF5 (PubMed:1280226, PubMed:31331973). Costimulates T-cell proliferation and cytokine production (PubMed:8617933). Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation (PubMed:8617933). Induces the activation of NF-kappa-B (PubMed:15067037, PubMed:31331973). Induces the activation of kinases MAPK8 and PAK2 in T-cells (PubMed:15067037). Induces tyrosine phosphorylation of isoform 3 of CD28 (PubMed:15067037). Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL4 (By similarity). Involved in immunoglobulin class switching (By similarity).</text>
</comment>
<comment type="function">
<molecule>CD40 ligand, soluble form</molecule>
<text evidence="10">Acts as a ligand for integrins, specifically ITGA5:ITGB1 and ITGAV:ITGB3; both integrins and the CD40 receptor are required for activation of CD40-CD40LG signaling, which have cell-type dependent effects, such as B-cell activation, NF-kappa-B signaling and anti-apoptotic signaling.</text>
</comment>
<comment type="subunit">
<text evidence="5 7 10 19 21">Homotrimer (PubMed:8626375, PubMed:11676606, PubMed:8589998). Interacts with isoform 3 of CD28 (PubMed:15067037). CD40 ligand, soluble form: Exists as either a monomer or a homotrimer (PubMed:8626375, PubMed:31331973). Forms a ternary complex between CD40 and integrins for CD40-CD40LG signaling (PubMed:31331973).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="21">Cell membrane</location>
<topology evidence="26">Single-pass type II membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="7 12">Cell surface</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>CD40 ligand, soluble form</molecule>
<subcellularLocation>
<location evidence="21">Secreted</location>
</subcellularLocation>
<text evidence="8">Release of soluble CD40L from platelets is partially regulated by GP IIb/IIIa, actin polymerization, and a matrix metalloproteinases (MMP) inhibitor-sensitive pathway.</text>
</comment>
<comment type="tissue specificity">
<text>Specifically expressed on activated CD4+ T-lymphocytes.</text>
</comment>
<comment type="PTM">
<text evidence="21">The soluble form derives from the membrane form by proteolytic processing.</text>
</comment>
<comment type="PTM">
<text evidence="5">N-linked glycan is a mixture of high mannose and complex type. Glycan structure does not influence binding affinity to CD40.</text>
</comment>
<comment type="PTM">
<text>Not O-glycosylated.</text>
</comment>
<comment type="disease" evidence="9 10 11 13 14 15 16 17 18 22 23 24">
<disease id="DI-02449">
<name>Immunodeficiency with hyper-IgM, type 1</name>
<acronym>HIGM1</acronym>
<description>Immunoglobulin isotype switch defect characterized by elevated concentrations of serum IgM and decreased amounts of all other isotypes. Affected males present at an early age (usually within the first year of life) recurrent bacterial and opportunistic infections, including Pneumocystis carinii pneumonia and intractable diarrhea due to cryptosporidium infection. Despite substitution treatment with intravenous immunoglobulin, the overall prognosis is rather poor, with a death rate of about 10% before adolescence.</description>
<dbReference type="MIM" id="308230"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="27">Belongs to the tumor necrosis factor family.</text>
</comment>
<comment type="online information" name="CD40Lbase">
<link uri="http://structure.bmc.lu.se/idbase/CD40Lbase/"/>
<text>CD40L defect database</text>
</comment>
<dbReference type="EMBL" id="X68550">
<property type="protein sequence ID" value="CAA48554.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z15017">
<property type="protein sequence ID" value="CAA78737.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X67878">
<property type="protein sequence ID" value="CAA48077.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L07414">
<property type="protein sequence ID" value="AAA35662.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D31797">
<property type="protein sequence ID" value="BAA06599.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC071754">
<property type="protein sequence ID" value="AAH71754.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC074950">
<property type="protein sequence ID" value="AAH74950.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14659.1"/>
<dbReference type="PIR" id="S28017">
<property type="entry name" value="I53476"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000065.1">
<property type="nucleotide sequence ID" value="NM_000074.2"/>
</dbReference>
<dbReference type="PDB" id="1ALY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=116-261"/>
</dbReference>
<dbReference type="PDB" id="1I9R">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B/C=116-261"/>
</dbReference>
<dbReference type="PDB" id="3LKJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C=121-261"/>
</dbReference>
<dbReference type="PDB" id="3QD6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B/C/D/E/F=116-261"/>
</dbReference>
<dbReference type="PDB" id="6BRB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.82"/>
<property type="chains" value="A=120-261"/>
</dbReference>
<dbReference type="PDBsum" id="1ALY"/>
<dbReference type="PDBsum" id="1I9R"/>
<dbReference type="PDBsum" id="3LKJ"/>
<dbReference type="PDBsum" id="3QD6"/>
<dbReference type="PDBsum" id="6BRB"/>
<dbReference type="SMR" id="P29965"/>
<dbReference type="BioGRID" id="107397">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="DIP" id="DIP-3013N"/>
<dbReference type="STRING" id="9606.ENSP00000359663"/>
<dbReference type="ChEMBL" id="CHEMBL3580491"/>
<dbReference type="DrugBank" id="DB06475">
<property type="generic name" value="Ruplizumab"/>
</dbReference>
<dbReference type="GlyConnect" id="610">
<property type="glycosylation" value="12 N-Linked glycans"/>
</dbReference>
<dbReference type="GlyGen" id="P29965">
<property type="glycosylation" value="1 site, 23 N-linked glycans (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="P29965"/>
<dbReference type="PhosphoSitePlus" id="P29965"/>
<dbReference type="UniCarbKB" id="P29965"/>
<dbReference type="BioMuta" id="CD40LG"/>
<dbReference type="DMDM" id="231718"/>
<dbReference type="MassIVE" id="P29965"/>
<dbReference type="MaxQB" id="P29965"/>
<dbReference type="PaxDb" id="P29965"/>
<dbReference type="PeptideAtlas" id="P29965"/>
<dbReference type="PRIDE" id="P29965"/>
<dbReference type="ProteomicsDB" id="54611"/>
<dbReference type="ABCD" id="P29965">
<property type="antibodies" value="6 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="16693">
<property type="antibodies" value="1966 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="959"/>
<dbReference type="Ensembl" id="ENST00000370629">
<property type="protein sequence ID" value="ENSP00000359663"/>
<property type="gene ID" value="ENSG00000102245"/>
</dbReference>
<dbReference type="GeneID" id="959"/>
<dbReference type="KEGG" id="hsa:959"/>
<dbReference type="UCSC" id="uc004faa.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="959"/>
<dbReference type="DisGeNET" id="959"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000102245.7"/>
<dbReference type="GeneCards" id="CD40LG"/>
<dbReference type="GeneReviews" id="CD40LG"/>
<dbReference type="HGNC" id="HGNC:11935">
<property type="gene designation" value="CD40LG"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000102245">
<property type="expression patterns" value="Group enriched (blood, intestine, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="CD40LG"/>
<dbReference type="MIM" id="300386">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="308230">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P29965"/>
<dbReference type="OpenTargets" id="ENSG00000102245"/>
<dbReference type="Orphanet" id="101088">
<property type="disease" value="X-linked hyper-IgM syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36626"/>
<dbReference type="eggNOG" id="KOG3656">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214425"/>
<dbReference type="InParanoid" id="P29965"/>
<dbReference type="KO" id="K03161"/>
<dbReference type="OMA" id="MKMDKME"/>
<dbReference type="OrthoDB" id="1146113at2759"/>
<dbReference type="PhylomeDB" id="P29965"/>
<dbReference type="TreeFam" id="TF332169"/>
<dbReference type="PathwayCommons" id="P29965"/>
<dbReference type="Reactome" id="R-HSA-198933">
<property type="pathway name" value="Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5668541">
<property type="pathway name" value="TNFR2 non-canonical NF-kB pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5676594">
<property type="pathway name" value="TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"/>
</dbReference>
<dbReference type="SIGNOR" id="P29965"/>
<dbReference type="BioGRID-ORCS" id="959">
<property type="hits" value="4 hits in 501 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P29965"/>
<dbReference type="GeneWiki" id="CD154"/>
<dbReference type="GenomeRNAi" id="959"/>
<dbReference type="Pharos" id="P29965">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P29965"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="RNAct" id="P29965">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000102245">
<property type="expression patterns" value="Expressed in leukocyte and 85 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P29965">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P29965">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005174">
<property type="term" value="F:CD40 receptor binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005125">
<property type="term" value="F:cytokine activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005178">
<property type="term" value="F:integrin binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005164">
<property type="term" value="F:tumor necrosis factor receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0007257">
<property type="term" value="P:activation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030183">
<property type="term" value="P:B cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042100">
<property type="term" value="P:B cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0023035">
<property type="term" value="P:CD40 signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048305">
<property type="term" value="P:immunoglobulin secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045190">
<property type="term" value="P:isotype switching"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007159">
<property type="term" value="P:leukocyte cell-cell adhesion"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000353">
<property type="term" value="P:positive regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032733">
<property type="term" value="P:positive regulation of interleukin-10 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032735">
<property type="term" value="P:positive regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032753">
<property type="term" value="P:positive regulation of interleukin-4 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042102">
<property type="term" value="P:positive regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051023">
<property type="term" value="P:regulation of immunoglobulin secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031295">
<property type="term" value="P:T cell costimulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033209">
<property type="term" value="P:tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd00184">
<property type="entry name" value="TNF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.120.40">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR003263">
<property type="entry name" value="CD40L"/>
</dbReference>
<dbReference type="InterPro" id="IPR021184">
<property type="entry name" value="TNF_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR006052">
<property type="entry name" value="TNF_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008983">
<property type="entry name" value="Tumour_necrosis_fac-like_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11471:SF5">
<property type="entry name" value="PTHR11471:SF5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00229">
<property type="entry name" value="TNF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF016527">
<property type="entry name" value="TNF_5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01702">
<property type="entry name" value="CD40LIGAND"/>
</dbReference>
<dbReference type="SMART" id="SM00207">
<property type="entry name" value="TNF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49842">
<property type="entry name" value="SSF49842"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00251">
<property type="entry name" value="TNF_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50049">
<property type="entry name" value="TNF_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0202">Cytokine</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="CD40 ligand, membrane form" id="PRO_0000034484">
<location>
<begin position="1"/>
<end position="261"/>
</location>
</feature>
<feature type="chain" description="CD40 ligand, soluble form" id="PRO_0000034485" evidence="21">
<location>
<begin position="113"/>
<end position="261"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="4">
<location>
<begin position="23"/>
<end position="46"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="47"/>
<end position="261"/>
</location>
</feature>
<feature type="site" description="Cleavage">
<location>
<begin position="112"/>
<end position="113"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine; alternate" evidence="5">
<location>
<position position="240"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (high mannose) asparagine; alternate" evidence="5">
<location>
<position position="240"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="178"/>
<end position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; dbSNP:rs104894774." id="VAR_007513" evidence="14 23">
<original>M</original>
<variation>R</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_017925" evidence="22">
<original>G</original>
<variation>R</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_017929">
<original>G</original>
<variation>R</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_017930" evidence="9 24">
<original>G</original>
<variation>S</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; dbSNP:rs104894778." id="VAR_007514" evidence="17">
<original>A</original>
<variation>E</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_017926" evidence="22">
<original>H</original>
<variation>R</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_007515" evidence="16">
<original>V</original>
<variation>A</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_017931">
<original>V</original>
<variation>D</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_007516">
<original>SE</original>
<variation>RG</variation>
<location>
<begin position="128"/>
<end position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_007517" evidence="23">
<original>W</original>
<variation>C</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; dbSNP:rs104894777." id="VAR_007518" evidence="14">
<original>W</original>
<variation>G</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_007519" evidence="16">
<original>W</original>
<variation>R</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_017932">
<original>K</original>
<variation>T</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; dbSNP:rs886039326." id="VAR_007520" evidence="16">
<original>G</original>
<variation>E</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; dbSNP:rs1057521127." id="VAR_017922" evidence="24">
<original>T</original>
<variation>N</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; dbSNP:rs104894769." id="VAR_007521" evidence="15 18">
<original>L</original>
<variation>P</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; decreases ITGA5:ITGB1 and ITGAV:ITGB3 binding of the soluble form; decreases activation of NF-kappa-B signaling; slightly decreases CD40 binding of the soluble form; dbSNP:rs756468554." id="VAR_017923" evidence="10 24">
<original>Y</original>
<variation>C</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_017933">
<original>A</original>
<variation>D</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; decreases ITGA5:ITGB1 and ITGAV:ITGB3 binding of the soluble form; decreases activation of NF-kappa-B signaling." id="VAR_017927" evidence="10 22">
<original>Q</original>
<variation>R</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; decreases ITGA5:ITGB1 and ITGAV:ITGB3 binding of the soluble form; decreases activation of NF-kappa-B signaling." id="VAR_017934" evidence="10">
<original>T</original>
<variation>I</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_017935">
<original>L</original>
<variation>P</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; decreases ITGA5:ITGB1 and ITGAV:ITGB3 binding of the soluble form; decreases activation of NF-kappa-B signaling." id="VAR_017936" evidence="10">
<original>A</original>
<variation>D</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_007522" evidence="15">
<original>T</original>
<variation>N</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs148594123." id="VAR_007523" evidence="18">
<original>G</original>
<variation>R</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; no effect on ITGA5:ITGB1 and ITGAV:ITGB3 binding of the soluble form; increases NF-kappa-B signaling." id="VAR_017937" evidence="10">
<original>H</original>
<variation>Y</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; no effect on ITGA5:ITGB1 and ITGAV:ITGB3 binding of the soluble form; slightly increases NF-kappa-B signaling." id="VAR_017938" evidence="10">
<original>G</original>
<variation>A</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; decreases ITGA5:ITGB1 and ITGAV:ITGB3 binding of the soluble form; decreases activation of NF-kappa-B signaling; dbSNP:rs104894768." id="VAR_007524" evidence="10 15 18 24">
<original>G</original>
<variation>V</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_007525" evidence="23">
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_007526" evidence="23 24">
<original>L</original>
<variation>S</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; dbSNP:rs104894771." id="VAR_007527" evidence="13 24">
<original>A</original>
<variation>P</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_017939" evidence="11">
<original>V</original>
<variation>E</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; dbSNP:rs193922136." id="VAR_007528" evidence="23 24">
<original>T</original>
<variation>M</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; dbSNP:rs1477466218." id="VAR_017940">
<original>G</original>
<variation>D</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1." id="VAR_017928" evidence="22">
<original>G</original>
<variation>S</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In HIGM1; decreases ITGA5:ITGB1 and ITGAV:ITGB3 binding of the soluble form; decreases activation of NF-kappa-B signaling." id="VAR_017924" evidence="10 24">
<original>L</original>
<variation>S</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ITGA5:ITGB1 binding, B-cell activation, activation of NF-kappa-B signaling, and anti-apoptotic signaling; in soluble form. Slightly decreases CD40 binding; in soluble form." evidence="10">
<original>Y</original>
<variation>E</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ITGA5:ITGB1 binding, B-cell activation, activation of NF-kappa-B signaling, and anti-apoptotic signaling; when associated with E-226 in soluble form. No effect on CD40 binding; when associated with E-226 in soluble form." evidence="10">
<original>H</original>
<variation>E</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ITGA5:ITGB1 binding, B-cell activation, activation of NF-kappa-B signaling, and anti-apoptotic signaling; when associated with E-224 in soluble form. No effect on CD40 binding; when associated with E-224 in soluble form." evidence="10">
<original>G</original>
<variation>E</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ITGA5:ITGB1 binding, B-cell activation, activation of NF-kappa-B signaling, and anti-apoptotic signaling; in soluble form. No effect on CD40 binding; in soluble form." evidence="10">
<original>G</original>
<variation>E</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="123"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="132"/>
<end position="134"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="140"/>
<end position="142"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="153"/>
<end position="156"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="157"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="160"/>
<end position="165"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="167"/>
<end position="179"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="186"/>
<end position="195"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="203"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="218"/>
<end position="232"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="237"/>
<end position="242"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="244"/>
<end position="246"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="251"/>
<end position="260"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ALY"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6BRB"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P27548"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11676606"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1280226"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15067037"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15193700"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26545377"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31331973"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7532185"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7678552"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7678782"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7679206"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7679801"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7717401"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8094231"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8550833"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8589998"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8617933"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8626375"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8889581"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9150729"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9746782"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="31331973"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8626375"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<sequence length="261" mass="29274" checksum="16F5CEB093BCC2BB" modified="1993-04-01" version="1">MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>
